Mechanisms of SHP‐1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV‐1‐transformed T cells

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Leukocyte Biology

• Publication date

  2008-10-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1189/jlb.0608383PMID 18948549PMCID PMC2626764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PU.1: a crucial and versatile player in hematopoiesis and leukemia.

  2008cited by this paper
• PU.1 Activates Transcription of SHP-1 Gene in Hematopoietic Cells*

  2007cited by this paper
• Decreased expression level of SH2 domain‐containing protein tyrosine phosphatase‐1 (Shp1) is associated with progression of chronic myeloid leukaemia

  2007cited by this paper
• Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma

  2006cited by this paper
• Targeting NF-kappaB in hematologic malignancies.

  2006cited by this paper
• SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis

  2006cited by this paper
• Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.

  2006cited by this paper
• Protein-tyrosine phosphatases and cancer

  2006cited by this paper
• Negative regulation of the SH2-homology-containing protein-tyrosine phosphatase-1 (Shp-1) P2 promoter by the HTLV-1 tax oncoprotein

  2006cited by this paper
• Targeting NF-κB in hematologic malignancies

  2006cited by this paper
• Tyrosine phosphatase SHP-1 acts at different stages of development to regulate hematopoiesis.

  2005cited by this paper
• STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes.

  2005influential reference
• Aberrant methylation of the negative regulators RASSFIA, SHP‐1 and SOCS‐1 in myelodysplastic syndromes and acute myeloid leukaemia

  2005cited by this paper
• Detection and interpretation of altered methylation patterns in cancer cells

  2005cited by this paper
• SHP1 expression in bone marrow biopsies of myelodysplastic syndrome patients: a new prognostic factor

  2005cited by this paper
• SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway.

  2004cited by this paper
• Methylation of SHP1 gene and loss of SHP1 protein expression are frequent in systemic anaplastic large cell lymphoma.

  2004cited by this paper
• Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias

  2004cited by this paper
• Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.

  2004cited by this paper
• Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity

  2004cited by this paper
• Activated Proliferation of B-Cell Lymphomas/Leukemias with the SHP1 Gene Silencing by Aberrant CpG Methylation

  2003cited by this paper
• Abnormal splicing of SHP-1 protein tyrosine phosphatase in human T cells. Implications for lymphomagenesis.

  2003cited by this paper
• The function of the protein tyrosine phosphatase SHP-1 in cancer.

  2003cited by this paper
• Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas.

  2002cited by this paper
• Molecular mechanisms underlying SHP-1 gene expression.

  2002cited by this paper
• SHP-1 expression in peripheral T cells from patients with Sezary syndrome and in the T cell line HUT-78: implications in JAK3-mediated signaling

  2002cited by this paper
• DNA methylation and chromatin – unraveling the tangled web

  2002cited by this paper
• Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray.

  2001cited by this paper
• Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases.

  2001cited by this paper
• RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia.

  2000cited by this paper
• Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.

  2000cited by this paper
• Constitutive Activation of NF-κB in Primary Adult T-Cell Leukemia Cells

  1999cited by this paper
• Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells.

  1999cited by this paper
• Constitutive Activation Of Nf- κ B In Primary Adult T-cell Leukemia Cells

  1999influential reference
• Human 70-kDa SHP-1L Differs from 68-kDa SHP-1 in Its C-terminal Structure and Catalytic Activity*

  1999cited by this paper
• Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells.

  1998cited by this paper
• Downregulated Expression of SHP-1 in Burkitt Lymphomas and Germinal Center B Lymphocytes

  1997cited by this paper
• Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13

  1992cited by this paper
• Chromosomal localization of an SH2-containing tyrosine phosphatase (PTPN6).

  1992cited by this paper

• Transcriptional Activation Mechanisms and Target Genes of the Oncogene Product Tax of Human T-Cell Leukemia Virus Type 1

  2025cites this paper
• Saliva as a feasible alternative to blood for interrogation of somatic hematopoietic variants

  2024cites this paper
• Next-Generation Sequencing Analysis of CpG Methylation of a Tumor Suppressor Gene SHP-1 Promoter in Stable Cell Lines and HCV-Positive Patients

  2022cites this paper
• Hepatitis C Virus Core Protein Down-Regulates Expression of Src-Homology 2 Domain Containing Protein Tyrosine Phosphatase by Modulating Promoter DNA Methylation

  2021influential citation
• A "hit-and-run" affair - A possible link for cancer progression in virally driven cancers.

  2020cites this paper
• CCR4-NOT transcription complex subunit 2 regulates TRAIL sensitivity in non-small-cell lung cancer cells via the STAT3 pathway

  2019cites this paper
• Epigallocatechin-3-gallate induces apoptosis in acute promyelocytic leukemia cells via a SHP-1-p38α MAPK-Bax cascade.

  2017cites this paper
• Quinalizarin enhances radiosensitivity of nasopharyngeal carcinoma cells partially by suppressing SHP-1 expression.

  2016cites this paper
• Non-transmembrane PTPs in Cancer

  2016cites this paper
• Protein Tyrosine Phosphatases in Cancer

  2016cites this paper
• Expression, prognostic significance and mutational analysis of protein tyrosine phosphatase SHP-1 in chronic myeloid leukemia

  2016cites this paper
• Deciphering the role of DNA methylation in multiple sclerosis: emerging issues

  2016cites this paper
• SHP-1 overexpression increases the radioresistance of NPC cells by enhancing DSB repair, increasing S phase arrest and decreasing cell apoptosis.

  2015cites this paper
• Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia

  2015cites this paper
• Methylated alteration of SHP1 complements mutation of JAK2 tyrosine kinase in patients with myeloproliferative neoplasm.

  2015cites this paper
• The SHP-1 expression is associated with cytokines and psychopathological status in unmedicated first episode schizophrenia patients.

  2014cites this paper
• SC-2001 Overcomes STAT3-mediated Sorafenib Resistance through RFX-1/SHP-1 Activation in Hepatocellular Carcinoma

  2014cites this paper
• RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.

  2014cites this paper
• Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

  2013cites this paper
• Epigenetics and Human Infectious Diseases

  2012cites this paper
• Role of ceacam1 and shp1 in the regulation of insulin sensitivity and hepatic glucose and lipid metabolism

  2012cites this paper
• Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.

  2012influential citation
• Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease

  2012cites this paper
• Patho-Epigenetics of Disease

  2012cites this paper
• Epigenetic Changes in Virus-Associated Neoplasms

  2012cites this paper
• Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6/SHP1) may contribute to neutrophilic dermatoses.

  2011cites this paper
• Viral hit and run-oncogenesis: genetic and epigenetic scenarios.

  2011cites this paper
• SH2 Domain-Containing Protein-Tyrosine Phosphatases

  2010cites this paper
• Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy

  2009cites this paper
• Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype

  2009cites this paper